Product Platforms


T +31 20 444 2254

Subscribe to newsletters



Translational medicine is the transformation of laboratory research outcomes into new ways to diagnose and treat patients to improve the health of millions of people worldwide. It takes promising biomedical innovations 'from bench to bedside' and bridges clinical needs from bedside to bench.

EATRIS provides a new development pathway, open to researchers and companies in need of support for advancing biomedical innovations. EATRIS comprises over 70 leading academic institutions across Europe, each renowned for its individual and high-end research facilities.

This infrastructure provides the following advantages:

  • Single point of access to the right expertise and facilities
  • Expedites the development process
  • Access to large and diverse clinical patient cohorts


EMA News

The European Medicines Agency (EMA) has adopted a landmark policy to take effect on 1 January 2015.

Read more
News Item 2

BBMRI collaboration

The importance of the role of biobanking within biomedical research is recognized through the collaboration between EATRIS-ERIC and BBMRI-ERIC. Read more

News Item 1

Roche EIN

EATRIS enters framework agreement with Roche to access Europe-wide network of translational researchers.

Read more




5 February 2015

Innovation for Health - Shaping the future of healthcare together, the Netherlands.

13 January 2015

1st Danish Symposium on Biomarkers and the Implementation of Personalized Medicine to the Clinic, Copenhagen.

26 October 2014

8th Vaccine & ISU Congress The 8th annual Vaccine and ISU Congress will take place over 3 days in Philadelphia, USA.

13 October 2014

World Vaccine Congress 2014 - Europe's leading 3 day conference and exhibition for the vaccine industry to be held in Brussels, Belgium.